Citation Impact
Citing Papers
Lipoprotein-associated phospholipase A2 and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies
2010
The Effect of a Hypocaloric Diet with and without Exercise Training on Body Composition, Cardiometabolic Risk Profile, and Reproductive Function in Overweight and Obese Women with Polycystic Ovary Syndrome
2008
Anti-Müllerian Hormone Is a Marker of Gonadotoxicity in Pre- and Postpubertal Girls Treated for Cancer: A Prospective Study
2012
Sex Differences in the Cardiovascular Consequences of Diabetes Mellitus
2015
Infection, inflammation, height, and longevity
2005 Standout
Modeling Age at Menopause Using Serum Concentration of Anti-Mullerian Hormone
2013
Androgen Levels in Adult Females: Changes with Age, Menopause, and Oophorectomy
2005
Hippo signaling disruption and Akt stimulation of ovarian follicles for infertility treatment
2013 Standout
Obesity and Systemic Oxidative Stress
2003
Resumption of Ovarian Function and Pregnancies in 358 Patients with Premature Ovarian Failure
2011
Therapeutic elevation of HDL-cholesterol to prevent atherosclerosis and coronary heart disease
2006
Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society
2011
A randomized, 48-week, placebo-controlled trial of intensive lifestyle modification and/or metformin therapy in overweight women with polycystic ovary syndrome: A pilot study
2004
Breast cancer
2016 Standout
Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline
2008
Relationship between endogenous testosterone and cardiovascular risk in early postmenopausal women
2008
Impact of cancer therapies on ovarian reserve
2011
Effects of Torcetrapib in Patients at High Risk for Coronary Events
2007 Standout
Increased oxidative stress in obesity and its impact on metabolic syndrome
2004 Standout
The complex interaction between obesity, metabolic syndrome and reproductive axis: A narrative review
2012
The polycystic ovary syndrome: a position statement from the European Society of Endocrinology
2014
Evaluation of serum antimullerian hormone and inhibin B concentrations in the differential diagnosis of secondary oligoamenorrhea
2011
Metabolic syndrome meets osteoarthritis
2012
Pro-resolving lipid mediators are leads for resolution physiology
2014 StandoutNature
Phospholipase A2 inhibition and atherosclerotic vascular disease: prospects for targeting secretory and lipoprotein-associated phospholipase A2 enzymes
2010
Phospholipase A2s: Developing drug targets for atherosclerosis
2010
Effects of Varespladib Methyl on Biomarkers and Major Cardiovascular Events in Acute Coronary Syndrome Patients
2010
Macrophages in the Pathogenesis of Atherosclerosis
2011 Standout
Mechanisms of Disease: proatherogenic HDL—an evolving field
2006
Normal serum anti-Müllerian hormone levels in the general female population and the relationship with reproductive history
2012
Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries
2011
The Science of Stroke: Mechanisms in Search of Treatments
2010 Standout
Uric Acid and Cardiovascular Risk
2008 Standout
Intra-cycle fluctuations of anti-Müllerian hormone in normal women with a regular cycle: a re-analysis
2012
Individual serum levels of anti-Mullerian hormone in healthy girls persist through childhood and adolescence: a longitudinal cohort study
2012
Hyperinsulinemia and circulating dehydroepiandrosterone sulfate in white and Mexican American women with polycystic ovary syndrome
2006
The physiology and clinical utility of anti-Müllerian hormone in women
2014 Standout
Prenatal stress and risk for autism
2008
Perimenopause as a neurological transition state
2015
Prevalence and Trends in Obesity Among US Adults, 1999-2008
2010 Standout
The medical complications of obesity
2006
Onset of Ovulation after Menarche in Girls: A Longitudinal Study
2008
Elevated circulating levels of markers of oxidative-nitrative stress and inflammation in a genetic rat model of metabolic syndrome
2006
Inflammation and insulin resistance
2006 Standout
A stress response pathway regulates DNA damage through β2-adrenoreceptors and β-arrestin-1
2011 StandoutNatureNobel
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Usefulness of Elevations in Serum Choline and Free F2-Isoprostane to Predict 30-Day Cardiovascular Outcomes in Patients With Acute Coronary Syndrome
2009
Cholesterol efflux pathways and other potential mechanisms involved in the athero‐protective effect of high density lipoproteins
2008
Updated ultrasound criteria for polycystic ovary syndrome: reliable thresholds for elevated follicle population and ovarian volume
2013
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
2013 Standout
Skeletal remodeling in health and disease
2007 Standout
Gonadal function and parenthood 20 years after treatment for childhood lymphoma: A cross‐sectional study
2011
Increasing plasma fatty acids elevates F2-isoprostanes in humans: implications for the cardiovascular risk factor cluster
2002
A Validated Model of Serum Anti-Müllerian Hormone from Conception to Menopause
2011
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
A Systematic Review of Overweight, Obesity, and Type 2 Diabetes Among Asian American Subgroups
2013
Platelet Activation and Atherothrombosis
2007 Standout
Polycystic ovarian morphology in adolescents with regular menstrual cycles is associated with elevated anti-Mullerian hormone
2011
Increased telomerase activity and comprehensive lifestyle changes: a pilot study
2008 StandoutNobel
Intensive Lowering of Low-Density Lipoprotein Cholesterol Levels for Primary Prevention of Coronary Artery Disease
2009
Measuring anti-Müllerian hormone for the assessment of ovarian reserve: When and for whom is it indicated?
2011
Products of the isoprostane pathway: unique bioactive compounds and markers of lipid peroxidation
2002
Targeting Cholesteryl Ester Transfer Protein for the Prevention and Management of Cardiovascular Disease
2006
Epidemiology of Osteoarthritis
2008
Beyond High-Density Lipoprotein Cholesterol Levels
2008
Polycystic Ovary Syndrome
2005 Standout
Adolescent Anovulation: Maturational Mechanisms and Implications
2013
Elevated serum anti-Müllerian hormone in adolescents with polycystic ovary syndrome: relationship to ultrasound features
2012
Increased F2 isoprostane plasma levels in patients with congestive heart failure are correlated with antioxidant status and disease severity
2004
Origin and physiological roles of inflammation
2008 StandoutNature
Variation in antimüllerian hormone concentration during the menstrual cycle may change the clinical classification of the ovarian response
2013
The Influence of Pravastatin and Atorvastatin on Markers of Oxidative Stress in Hypercholesterolemic Humans
2008
Clinical, ultrasound and biochemical features of polycystic ovary syndrome in adolescents: implications for diagnosis
2011
The Oxidative Modification Hypothesis of Atherosclerosis Does It Hold for Humans?
2001
What We Talk About When We Talk About Fat
2014 Standout
A normotriglyceridemic, low HDL-cholesterol phenotype is characterised by elevated oxidative stress and HDL particles with attenuated antioxidative activity
2005
Progress and challenges in translating the biology of atherosclerosis
2011 StandoutNature
Direct and indirect anticancer activity of bisphosphonates: A brief review of published literature
2011
Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group
2011 Standout
Sex differences in immune responses
2016 Standout
Anti-Müllerian Hormone Predicts Menopause: A Long-Term Follow-Up Study in Normoovulatory Women
2011
Secretory phospholipase A2: A multifaceted family of proatherogenic enzymes
2009
Anti-Mullerian hormone (AMH): what do we still need to know?
2009
Polycystic ovaries at ultrasound: normal variant or silent polycystic ovary syndrome?
2012
Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART)
2009
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
2008 Standout
Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis
2011 Standout
Antimüllerian hormone levels are independently related to ovarian hyperandrogenism and polycystic ovaries
2012
Can Anti-Müllerian Hormone Predict the Diagnosis of Polycystic Ovary Syndrome? A Systematic Review and Meta-Analysis of Extracted Data
2013
Nomogram for the decline in serum antimüllerian hormone: a population study of 9,601 infertility patients
2010
Correlation of ovarian reserve tests with histologically determined primordial follicle number
2010
Pretreatment Serum Anti-Müllerian Hormone Predicts Long-Term Ovarian Function and Bone Mass after Chemotherapy for Early Breast Cancer
2011
Osteoarthritis
2019 Standout
Pretreatment antimüllerian hormone levels determine rate of posttherapy ovarian reserve recovery: acute changes in ovarian reserve during and after chemotherapy
2012
The Diagnosis of Polycystic Ovary Syndrome during Adolescence
2015 Standout
Interpreting human follicular recruitment and antimüllerian hormone concentrations throughout life
2012
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
2009 Standout
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
2011 StandoutNature
Release of Free F2-isoprostanes from Esterified Phospholipids Is Catalyzed by Intracellular and Plasma Platelet-activating Factor Acetylhydrolases
2005
Biomarkers in Heart Failure
2008 Standout
A single test of antimüllerian hormone in late reproductive-aged women is a good predictor of menopause
2009
First international consensus guidelines for breast cancer in young women (BCY1)
2014
Assessment of ovarian reserve in adult childhood cancer survivors using anti-Mullerian hormone
2008
Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis
2006 Standout
Measurement of F2-isoprostanes as an index of oxidative stress in vivo
2000
Activation of Oxidative Stress by Acute Glucose Fluctuations Compared With Sustained Chronic Hyperglycemia in Patients With Type 2 Diabetes
2006 Standout
The Many Roles of Chemokines and Chemokine Receptors in Inflammation
2006 Standout
Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society
2013
Application of Gas Chromatography-Mass Spectrometry for Analysis of Isoprostanes: Their Role in Cardiovascular Disease
2003
Lipid Oxidation and Peroxidation in CNS Health and Disease: From Molecular Mechanisms to Therapeutic Opportunities
2009
Factors Regulating Isoprostane Formation In Vivo
2004
The Complex Role of Estrogens in Inflammation
2007 Standout
Quantification of Isoprostanes as Indices of Oxidant Stress and the Risk of Atherosclerosis in Humans
2005
Gene therapy for dyslipidemia: a review of gene replacement and gene inhibition strategies
2010
Circulating sex hormones and breast cancer risk factors in postmenopausal women: reanalysis of 13 studies
2011 Standout
Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss
2005 Standout
Lymphoid tissue phospholipase A2 group IID resolves contact hypersensitivity by driving antiinflammatory lipid mediators
2013
Polycystic Ovary-Like Abnormalities (PCO-L) in Women with Functional Hypothalamic Amenorrhea
2012
Prevalence of and Trends in Diabetes Among Adults in the United States, 1988-2012
2015 Standout
A multicentre evaluation of the new Beckman Coulter anti-Müllerian hormone immunoassay (AMH Gen II)
2011
Mitochondrial DNA Mutations, Oxidative Stress, and Apoptosis in Mammalian Aging
2005 StandoutScience
Val64Ile Polymorphism in the C-C Chemokine Receptor 2 Is Associated With Reduced Coronary Artery Calcification
2002
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Macrophage Reverse Cholesterol Transport
2006
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Obesity and PCOS: Implications for Diagnosis and Treatment
2012
Lipoprotein-Associated and Secreted Phospholipases A 2 in Cardiovascular Disease
2010
A rational approach to the diagnosis of polycystic ovarian syndrome during adolescence
2011
The fetal origins of atherosclerosis: maternal hypercholesterolemia, and cholesterol‐lowering or antioxidant treatment during pregnancy influence in utero programming and postnatal susceptibility to atherogenesis
2002
Knee osteoarthritis has doubled in prevalence since the mid-20th century
2017 Standout
Emerging roles of secreted phospholipase A2 enzymes: Lessons from transgenic and knockout mice
2010
Increased F 2 ‐isoprostanes in Alzheimer's disease: evidence for enhanced lipid peroxidation in vivo
1998
Uric acid reduces exercise-induced oxidative stress in healthy adults
2003
Follicle-stimulating hormone stimulates TNF production from immune cells to enhance osteoblast and osteoclast formation
2006
Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
2012 Standout
Mammographic density. Potential mechanisms of breast cancer risk associated with mammographic density: hypotheses based on epidemiological evidence
2008
Phospholipase A2Enzymes: Physical Structure, Biological Function, Disease Implication, Chemical Inhibition, and Therapeutic Intervention
2011 Standout
Ovarian Aging: Mechanisms and Clinical Consequences
2009
Free Radicals in the Physiological Control of Cell Function
2002 Standout
Inflammatory Exposure and Historical Changes in Human Life-Spans
2004 StandoutScience
Creatine and Creatinine Metabolism
2000 Standout
Works of Daniel McConnell being referenced
Anti-Mullerian Hormone and Inhibin B in the Definition of Ovarian Aging and the Menopause Transition
2008
Dietary Fat Subgroups, Zinc, and Vegetable Components Are Related to Urine F2a-Isoprostane Concentration, a Measure of Oxidative Stress, in Midlife Women
2007
Anti-Müllerian hormone and inhibin B variability during normal menstrual cycles
2009
Effects of 1-H-indole-3-glyoxamide (A-002) on concentration of secretory phospholipase A2 (PLASMA study): a phase II double-blind, randomised, placebo-controlled trial
2009
Trajectory Clustering of Estradiol and Follicle-Stimulating Hormone during the Menopausal Transition among Women in the Study of Women's Health across the Nation (SWAN)
2012
Testosterone, sex hormone-binding globulin and free androgen index among adult women: chronological and ovarian aging
2009
The Relationship of Circulating Dehydroepiandrosterone, Testosterone, and Estradiol to Stages of the Menopausal Transition and Ethnicity
2002
Relating smoking, obesity, insulin resistance, and ovarian biomarker changes to the final menstrual period
2010
The Endothelium and Lipoproteins: Insights from Recent Cell Biology and Animal Studies
2000
Predictors of recovery of ovarian function during aromatase inhibitor therapy
2013
Estradiol and its metabolites and their association with knee osteoarthritis
2006
Androgens Are Associated with Hemostatic and Inflammatory Factors among Women at the Mid-Life
2005
Hormone Predictors of Bone Mineral Density Changes during the Menopausal Transition
2006
Reproductive Hormones in the Early Menopausal Transition: Relationship to Ethnicity, Body Size, and Menopausal Status
2003
The Polycystic Ovary Post-Rotterdam: A Common, Age-Dependent Finding in Ovulatory Women without Metabolic Significance
2010
Anti-Müllerian Hormone and Inhibin B in the Definition of Ovarian Aging and the Menopause Transition
2009
Assessing menstrual cycles with urinary hormone assays
2003
Cortisol levels and very early pregnancy loss in humans
2006
Estradiol Rates of Change in Relation to the Final Menstrual Period in a Population-Based Cohort of Women
2008
Circulating Bioactive Androgens in Midlife Women
2006
Increased Formation of Distinct F2Isoprostanes in Hypercholesterolemia
1998
Increased Atherosclerosis in Mice Lacking Apolipoprotein A-I Attributable to Both Impaired Reverse Cholesterol Transport and Increased Inflammation
2005
Circulating Dehydroepiandrosterone Sulfate Concentrations during the Menopausal Transition
2009
Apolipoprotein A-I Deficiency Results in Markedly Increased Atherosclerosis in Mice Lacking the LDL Receptor
2003
Association of Traditional Risk Factors with Coronary Calcification in Persons with a Family History of Premature Coronary Heart Disease: The Study of the Inherited Risk of Coronary Atherosclerosis
2001